Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,361 | 43,750 | -133,996 | -99,100 | -65,281 |
| Depreciation Amortization | 518 | 201 | 690 | 512 | 340 |
| Income taxes - deferred | 16,984 | 22,006 | N/A | 0 | N/A |
| Accounts payable and accrued liabilities | -598 | -6,269 | -6,446 | -8,387 | -8,923 |
| Other Working Capital | -1,972 | -4,618 | -5,895 | -7,295 | -9,275 |
| Other Operating Activity | -88,664 | -88,601 | 23,667 | 21,412 | 17,312 |
| Operating Cash Flow | $-65,371 | $-33,531 | $-121,980 | $-92,858 | $-65,827 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -226,927 | -245,700 | 158,745 | 96,774 | 61,734 |
| PPE Investments | -260 | -12 | -214 | -130 | N/A |
| Purchase Sale Intangibles | -5,000 | N/A | N/A | 0 | N/A |
| Other Investing Activity | 95,000 | 100,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-132,187 | $-145,712 | $158,531 | $96,644 | $61,734 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 165,968 | 165,585 | 2,009 | 1,589 | 890 |
| Financing Cash Flow | $165,968 | $165,585 | $2,009 | $1,589 | $890 |
| Beginning Cash Position | 101,257 | 101,257 | 62,697 | 62,697 | 62,697 |
| End Cash Position | 69,667 | 87,599 | 101,257 | 68,072 | 59,494 |
| Net Cash Flow | $-31,590 | $-13,658 | $38,560 | $5,375 | $-3,203 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,371 | -33,531 | -121,980 | -92,858 | -65,827 |
| Capital Expenditure | -260 | -12 | -214 | -130 | N/A |
| Free Cash Flow | -65,631 | -33,543 | -122,194 | -92,988 | -65,827 |